Epigenomes
Multidisciplinary Digital Publishing Institute (MDPI)
Switzerland
journal
SJR by Edition
Subject Categories
- BiochemistryQ1
- Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
- Health, Toxicology and MutagenesisQ1
- GeneticsQ2
Areas: Biochemistry, Genetics and Molecular Biology · Environmental Science
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
2075-4655
SJR Best Quartile
Q1
Region
Western Europe
Citations per Document (2 years)
4.42
References per Document
93.83
Coverage
2017-2025
Scope
Epigenetics, defined as the study of the information carried by the genome that is not encoded by DNA, as well as Epitranscriptomics, defined as the sum of the functionally relevant changes to the transcriptome that do not involve a direct change in the RNA sequence, are two of the most rapidly expanding fields, with clear therapeutic implications. The scope of Epigenomes includes, but is not limited to the following subjects: Functional studies dealing with identification/modus operandi/structure–function relationships or biological activity of methylases, demethylases, acetylases, methyl-binding proteins, or any other type of enzymes involved in DNA, RNA or histone modifications; Studies reporting genome-wide epigenetic status of cells or tissues in specific biologically relevant contexts; Studies describing insights into the role of epigenetics and epitranscriptomics in physical diseases (e.g., cancer, premature aging, allergy, obesity) and psychopathologies (e.g., schizophrenia, autism, addiction); Studies describing the effect of environmental changes on the epigenetic or epitranscriptomic status of cells or tissues; Studies describing the inheritance or fixation of epigenetic characteristics; Description of novel methods to study DNA methylation, histone methylation, RNA modifications, histone acetylation or other types of epigenetic and/or epitranscriptomic modifications in a global fashion; Studies describing novel tools and technologies for epigenetic or epitranscriptomic studies and therapeutics.
Metrics from SCImago Journal Rank 2025. View on SCImago